By Nqobile Dludla JOHANNESBURG (Reuters) -Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it ...

We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...

We recently compiled a list of the Top 10 Stocks to Buy According to Lone Pine Capital. In this article, we are going to take ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...

Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise ...

Tom Lilly has been a staple along sidelines across Eastern Iowa. The only head coach in Xavier girls basketball history is ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

China, India and the US will have the world’s largest populations of adults living with overweight and obesity by 2050, ...

California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...